Vitamin D – to whom, what and when?
Vitamin D – to whom, what and when? Clinical studies have confirmed that there are strong associations between a trio of hormones - parathyroid hormone, vitamin D and fibroblast growth factor 23 - and myocardial pathology. For example, vitamin D deficiency has been associated with the development of LVH in children with CKD. Similarly, high PTH levels have been described to be associated independently with LVH and increased concentrations of markers of cardiac damage and dysfunction (eg, troponin T and N-terminal pro–brain natriuretic peptide [NT-proBNP]).